Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer

This publication has 16 references indexed in Scilit:

• Esophageal cancer: results of an American College of Surgeons patient care evaluation study
  Journal of the American College of Surgeons, 2000
• Outpatient 5-Fluorouracil, Folinic Acid and Cisplatin in Patients with Advanced Esophageal Carcinoma
  Acta Oncologica, 1999
• Oesophageal cancer treatment: Studies, strategies and facts
  Annals of Oncology, 1998
• Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the Esophagus
  New England Journal of Medicine, 1997
• Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer
  European Journal Of Cancer, 1997
• Clinical benefit with cisplatin, hydroxyurea and 5-fluorouracil/ leucovorin in advanced pancreatic adenocarcinoma
  European Journal Of Cancer, 1997
• Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study.
  Journal of Clinical Oncology, 1997
• The cellular interaction of 5-fluorouracil and cisplatin in a human colon carcinoma cell line
  European Journal Of Cancer, 1996
• Combined Chemotherapy and Radiotherapy Compared with Radiotherapy Alone in Patients with Cancer of the Esophagus
  New England Journal of Medicine, 1992
• High-dose folinic acid, 5-fluorouracil bolus and continuous infusion in poor-prognosis patients with advanced measurable gastric cancer
  Annals of Oncology, 1991